A detailed history of Tcw Group Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Tcw Group Inc holds 25,103 shares of ABT stock, worth $2.82 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
25,103
Previous 24,384 2.95%
Holding current value
$2.82 Million
Previous $2.77 Million 5.88%
% of portfolio
0.02%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$100.73 - $112.44 $72,424 - $80,844
719 Added 2.95%
25,103 $2.61 Million
Q1 2024

May 09, 2024

SELL
$109.52 - $120.96 $425,266 - $469,687
-3,883 Reduced 13.74%
24,384 $2.77 Million
Q4 2023

Feb 09, 2024

BUY
$90.19 - $110.4 $2.55 Million - $3.12 Million
28,267 New
28,267 $3.11 Million
Q2 2021

Jul 23, 2021

SELL
$105.79 - $124.53 $3.9 Million - $4.59 Million
-36,838 Closed
0 $0
Q1 2021

May 05, 2021

SELL
$108.84 - $128.23 $276,671 - $325,960
-2,542 Reduced 6.46%
36,838 $4.42 Million
Q4 2020

Feb 02, 2021

BUY
$105.0 - $114.42 $104,475 - $113,847
995 Added 2.59%
39,380 $4.31 Million
Q2 2020

Aug 05, 2020

SELL
$76.57 - $98.0 $11,485 - $14,700
-150 Reduced 0.39%
38,385 $3.51 Million
Q1 2020

May 05, 2020

SELL
$62.82 - $91.86 $108,364 - $158,458
-1,725 Reduced 4.28%
38,535 $3.04 Million
Q4 2019

Feb 10, 2020

BUY
$78.51 - $87.4 $978,313 - $1.09 Million
12,461 Added 44.83%
40,260 $3.5 Million
Q3 2019

Nov 13, 2019

BUY
$81.84 - $88.74 $369,671 - $400,838
4,517 Added 19.4%
27,799 $2.33 Million
Q2 2019

Aug 07, 2019

BUY
$72.88 - $85.0 $12,535 - $14,620
172 Added 0.74%
23,282 $1.96 Million
Q4 2018

Feb 11, 2019

BUY
$65.56 - $74.27 $1.52 Million - $1.72 Million
23,110 New
23,110 $1.67 Million
Q4 2017

Feb 09, 2018

SELL
$53.68 - $57.47 $1.04 Million - $1.11 Million
-19,360 Closed
0 $0
Q2 2017

Aug 11, 2017

BUY
N/A
19,360
19,360 $941,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Tcw Group Inc Portfolio

Follow Tcw Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tcw Group Inc with notifications on news.